biote Corp.

biote Corp.

BTMD·NASDAQ

$2.30

+9.0%
HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

At a Glance

Live Snapshot
Market Cap$101.45M
EPS0.8600
P/E Ratio2.67
Earnings Date08/05/2026

btmd

Property, Plant, and Equipment (Net)

Last Annual Value

13.45M

3-Year CAGR

56%

5-Year CAGR

44%

10-Year CAGR

17%

biote Corp.

biote Corp. Competitors Analysis of Property, Plant, and Equipment (Net)

BTMD · NASDAQ
CompanyProperty, Plant, and Equipment (Net)
CAGR 3Y
CAGR 5Y
CAGR 10Y
BTMD logo
biote Corp.
NASDAQ:BTMD
13.45M
63.2%38.0%N/A 
66.26M
0.6%-0.7%2.4%
3.47M
-58.9%-31.2%N/A
2.62B
896.7%385.3%N/A
DCGO logo
DocGo Inc.
NASDAQ:DCGO
43.50M
4.2%10.6%N/A
926.00K
31.6%0.8%33.1%
11.53M
38.7%32.7%40.4%
13.08M
-11.8%3.0%N/A
LNSR logo
LENSAR, Inc.
NASDAQ:LNSR
505.00K
-63.4%-41.6%N/A
364.00K
-86.3%-68.7%N/A
1.48M
-29.1%-27.8%-0.1%
biote Corp.

biote Corp. Fair Value Envelope

BTMD · NASDAQ

Our analysis suggests that BTMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.3, this represents a potential HIDDEN relative to our calculated worth for biote Corp..

Intrinsic Value
Current Price: $2.3